PEcoma Market: Current Analysis and Forecast (2023-2030)


Emphasis on Devices Type [Diagnosis and Treatment (Chemotherapy, Targeted Therapy, Radiotherapy, and Others)]; End User (Hospitals, Diagnostic Centers, and Others); and Region/Country







Report ID:



  Get a Sample
Report Description
Table of content
Research Methodology

Report Description

PEcoma Market
PEcoma Market

The PEcoma market was valued at USD 45.5 million in 2022 and is expected to grow at a CAGR of around 5% from 2023-2030. Pecoma (Perivascular Epithelioid Cell) tumor, also known as PEComa, is a rare type of cancer that forms in the perivascular epithelioid cells. These cells typically line the walls of blood vessels and are situated in various organs within the body, such as the kidneys, lungs, liver, uterus, and gastrointestinal tract. PEComa tumors are known to be slow-growing and have the potential to metastasize, which makes early detection and treatment crucial. For instance, as per the National Organization for Rare Disorders, Malignant PEComas are estimated to be diagnosed in 0.12 to 0.24 per one million people.

Some of the major players operating in the market are Sarcoma Oncology Research Center LLC, Aadi Bioscience Inc, Novartis Pharmaceuticals, CENTOGENE GmbH Rostock, Antia Therapeutics AG, InCor Heart Institute, Children’s Hospital Medical Center, Johnson & Johnson, Pfizer, and Mylan N.V.

Insights Presented in the Report

“Amongst Type, the Treatment is expected to dominate during the forecast period.”

Based on the type, the market is segmented into diagnosis and Treatment. The treatment category dominated the market in 2022. Regarding therapeutic options, surgery is the primary treatment modality for PEComa, particularly for localized disease. Complete surgical resection is the aim, as it significantly improves patients’ outcomes. However, the effectiveness of surgery in advanced or metastatic cases is limited. Thus, there is a growing demand for targeted therapies that can effectively treat unresectable or metastatic PEComa.

“Amongst End User, the Hospital segment held the dominant share in 2022.”

On the basis of end-users, the market is categorized into Hospitals, diagnostic centers, and Others. Among these, the hospital’s category held a significant share of the market in 2022. This is mainly due to the high volume of PEcome surgeries and treatments performed in hospitals, as well as the availability of advanced medical equipment and expertise in this setting.

“Asia Pacific is expected to grow with the highest CAGR PEcoma market during the forecast period.”

The APAC region has witnessed a growing incidence and prevalence of PEComa cases, prompting increased attention from researchers, healthcare professionals, and pharmaceutical companies. Although the exact reasons behind this rise remain unclear, factors such as improved diagnostic techniques, enhanced awareness among clinicians, and demographic changes may have contributed to the identification of previously undiagnosed cases. Consequently, this surge has put a spotlight on the need for improved understanding, treatment options, and market potential within the region.

 Report Coverage

PEcoma Market
PEcoma Market

Reasons to buy this report:

  • The study includes market sizing and forecasting analysis validated by authenticated key industry experts.
  • The report presents a quick review of overall industry performance at one glance.
  • The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolios, expansion strategies, and recent developments.
  • Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry.
  • The study comprehensively covers the market across different segments.
  • Deep dive regional level analysis of the industry.


Customization Options:

The global PEcoma market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.


You can also purchase parts of this report. Do you want to check out a section wise
price list?

1.1.Market Definitions
1.2.Main Objective
2.1.Research Process of the PEcoma Market 
2.2.Research Methodology of the PEcoma Market
2.3.Respondent Profile   
 7.2.2.Targeted Therapy
8.2.Diagnostic Centers
9.1.North America PEcoma Market
 9.1.3.Rest of North America
9.2.Europe PEcoma Market 
 9.2.6.Rest of Europe 
9.3.Asia-Pacific PEcoma Market 
 9.3.4.Rest of APAC 
9.4.Rest of the World PEcoma Market
10.1.Market Drivers
10.2.Market Challenges
10.3.Impact Analysis
13.1.Demand Side Analysis
13.2.Supply Side Analysis
15.1.Competitive Landscape 
 15.1.1.Porters Fiver Forces Analysis
16.1.Sarcoma Oncology Research Center LLC
16.2.Aadi Bioscience Inc  
16.3.Novartis Pharmaceuticals 
16.4.CENTOGENE GmbH Rostock 
16.5.Antia Therapeutics AG 
16.6.InCor Heart Institute 
16.7.Children’s Hospital Medical Center 
16.8.Johnson & Johnson  
16.10.Mylan N.V.   

Research Methodology

Research Methodology for the PEcoma Market Analysis (2023-2030)

Analyzing the historical market, estimating the current market, and forecasting the future market of the global PEcoma market were the three major steps undertaken to create and analyze the adoption of PEcoma in major regions globally. Exhaustive secondary research was conducted to collect the historical market numbers and estimate the current market size. Secondly, to validate these insights, numerous findings and assumptions were taken into consideration. Moreover, exhaustive primary interviews were also conducted, with industry experts across the value chain of global PEcoma market. Post assumption and validation of market numbers through primary interviews, we employed a top-down/bottom-up approach to forecasting the complete market size. Thereafter, market breakdown and data triangulation methods were adopted to estimate and analyze the market size of segments and sub-segments of the industry pertains to. Detailed methodology is explained below:

Analysis of Historical Market Size

Step 1: In-Depth Study of Secondary Sources:

Detail secondary study was conducted to obtain the historical market size of the PEcoma market through company internal sources such as annual reports & financial statements, performance presentations, press releases, etc., and external sources including journals, news & articles, government publications, competitor publications, sector reports, third-party database, and other credible publications.

Step 2: Market Segmentation:

After obtaining the historical market size of the PEcoma market, we conducted a detailed secondary analysis to gather historical market insights and share for different segments & sub-segments for major regions. Major segments are included in the report as modality, service type, and specialist. Further country-level analyses were conducted to evaluate the overall adoption of testing models in that region.

Step 3: Factor Analysis:

After acquiring the historical market size of different segments and sub-segments, we conducted a detailed factor analysis to estimate the current market size of the PEcoma market. Further, we conducted factor analysis using dependent and independent variables such as modality, service type, and specialist of the PEcoma market. A thorough analysis was conducted for demand and supply-side scenarios considering top partnerships, mergers and acquisitions, business expansion, and product launches in the PEcoma market sector across the globe.

Current Market Size Estimate & Forecast

Current Market Sizing: Based on actionable insights from the above 3 steps, we arrived at the current market size, key players in the global PEcoma market, and market shares of the segments. All the required percentage shares split, and market breakdowns were determined using the above-mentioned secondary approach and were verified through primary interviews.

Estimation & Forecasting: For market estimation and forecast, weights were assigned to different factors including drivers & trends, restraints, and opportunities available for the stakeholders. After analyzing these factors, relevant forecasting techniques i.e., the top-down/bottom-up approach were applied to arrive at the market forecast for 2030 for different segments and sub-segments across the major markets globally. The research methodology adopted to estimate the market size encompasses:

  • The industry’s market size, in terms of revenue (USD) and the adoption rate of the PEcoma market across the major markets domestically
  • All percentage shares, splits, and breakdowns of market segments and sub-segments
  • Key players in the global PEcoma market in terms of products offered. Also, the growth strategies adopted by these players to compete in the fast-growing market


Market Size and Share Validation

Primary Research: In-depth interviews were conducted with the Key Opinion Leaders (KOLs) including Top Level Executives (CXO/VPs, Sales Head, Marketing Head, Operational Head, Regional Head, Country Head, etc.) across major regions. Primary research findings were then summarized, and statistical analysis was performed to prove the stated hypothesis. Inputs from primary research were consolidated with secondary findings, hence turning information into actionable insights.

Split of Primary Participants in Different Regions

PEcoma Market
PEcoma Market

Market Engineering

The data triangulation technique was employed to complete the overall market estimation and to arrive at precise statistical numbers for each segment and sub-segment of the global PEcoma market. data was split into several segments & sub-segments post studying various parameters and trends in the areas of the modality, service type, and specialist in the global PEcoma market.

The main objective of the Global PEcoma Market Study

The current & future market trends of the global PEcoma market were pinpointed in the study. Investors can gain strategic insights to base their discretion for investments on the qualitative and quantitative analysis performed in the study. Current and future market trends determined the overall attractiveness of the market at a regional level, providing a platform for the industrial participant to exploit the untapped market to benefit from a first-mover advantage. Other quantitative goals of the studies include:

  • Analyze the current and forecast market size of the PEcoma market in terms of value (USD). Also, analyze the current and forecast market size of different segments and sub-segments
  • Segments in the study include areas of modality, service type, and specialist.
  • Define and analysis of the regulatory framework for the PEcoma industry
  • Analyze the value chain involved with the presence of various intermediaries, along with analyzing customer and competitor behaviors of the industry
  • Analyze the current and forecast market size of the PEcoma market for the major region
  • Major countries of regions studied in the report include Asia Pacific, Europe, North America, and the Rest of the World
  • Company profiles of the PEcoma market and the growth strategies adopted by the market players to sustain in the fast-growing market
  • Deep dive regional level analysis of the industry.


You can also purchase parts of this report. Do you want to check out a section wise
price list?